BARBARA BELLFIELD: Open Payments
NPI 1295915825 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,816 in 174 payments from 31 companies in 2025. Trend: 2023 $3,288 · 2024 $4,137 · 2025 $4,816
Food & beverage: $3,816Long term medical supply or device loan: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $1,297 |
| AstraZeneca Pharmaceuticals LP | 16 | $385 |
| Janssen Biotech, Inc. | 11 | $250 |
| PFIZER INC. | 10 | $243 |
| E.R. Squibb & Sons, L.L.C. | 13 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $190 |
| Incyte Corporation | 7 | $181 |
| Merck Sharp & Dohme LLC | 7 | $178 |
| Celgene Corporation | 7 | $166 |
| Eisai Inc. | 7 | $148 |
Products named: KISQALI, ENHERTU, XTANDI, KEYTRUDA, JAKAFI, CARVYKTI, Lenvima, OPDUALAG.
Industry payments across CA — which companies pay providers there.
